
Discover the critical role of Lp(a) measurement in assessing cardiovascular risk and its potential impact on CVD prevention strategies.

Alex Fohl has been at Roche Diagnostics since 2017, focusing on the cardiac portfolio and is the Scientific Partner for Cardiometabolism. Prior to joining Roche, he was a clinical pharmacist at Indiana University Health in Indiana and Community Hospital in Indiana where he precepted students and residents.
Alex is a licensed pharmacist who earned his Doctor of Pharmacy degree from Purdue University and completed a two-year pharmacy practice residency in Critical Care from the University of Michigan Hospitals and Health Centers.